搜索临床试验以:[18F]NaF PET/CT 扫描
总计2960个结果
-
Peking University Cancer Hospital & InstituteBeijing Municipal Administration of Hospitals未知
-
Ontario Clinical Oncology Group (OCOG)Cancer Care Ontario主动,不招人
-
Amsterdam UMC, location VUmcRadboud University Medical Center; Leiden University Medical Center; Academisch Ziekenhuis Groningen 和其他合作者完全的
-
Latin American Cooperative Oncology GroupConselho Nacional de Desenvolvimento Científico e Tecnológico; Instituto do Cérebro do Rio Grande...完全的
-
Peking University Cancer Hospital & Institute未知
-
Peking University Cancer Hospital & InstituteBeijing Municipal Administration of Hospitals未知
-
Thomas Hope完全的复发性胶质母细胞瘤 | 复发性 WHO III 级神经胶质瘤 | 低级别胶质瘤 | 颅内肿瘤 | 复发性世界卫生组织 (WHO) II 级神经胶质瘤美国
-
National Cancer Institute (NCI)完全的IIIA期乳腺癌 | IIIB期乳腺癌 | IIB期乳腺癌 | IIIC期乳腺癌美国
-
University of UtahBlue Earth Diagnostics招聘中
-
Maastricht Radiation OncologyMaastricht University Medical Center终止
-
Mayo ClinicNational Cancer Institute (NCI)招聘中
-
Brigham and Women's HospitalDana-Farber Cancer Institute; Blue Earth Diagnostics尚未招聘
-
Radboud University Medical CenterAdenoid Cystic Carcinoma Research Foundation完全的
-
Washington University School of MedicineNational Cancer Institute (NCI)招聘中
-
ZionexaGE Healthcare; Simbec-Orion Group; Keosys招聘中
-
ZionexaGE Healthcare; Medpace, Inc.; Simbec-Orion Group终止
-
Peking University Cancer Hospital & Institute未知
-
Central Hospital, Nancy, France完全的
-
Guangdong Provincial People's Hospital招聘中
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Melanoma Research Alliance完全的
-
Barts & The London NHS TrustRoyal Marsden NHS Foundation Trust; Guy's and St Thomas' NHS Foundation Trust; Case Western Reserve... 和其他合作者完全的子宫内膜癌 | 手术分期的子宫内膜癌和宫颈癌 | 宫颈癌:侵袭性疾病,FIGO 1B1 期或更高 | 1A 期伴肌层浸润或任何更高阶段和 3 级 | 1A 期伴有肌层浸润或任何其他更高阶段和浆液性乳头状或透明细胞亚型 | II 期或以上疾病以及任何组织学分级英国
-
University of UtahNational Cancer Institute (NCI); MultiFunctional Imaging LLC完全的
-
Abramson Cancer Center of the University of Pennsylvania撤销新诊断为浸润性乳腺癌的成年女性(尚未接受治疗)